Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial

M J Pekka Raatikainen, Antti Hakalahti, Paavo Uusimaa, Jens Cosedis Nielsen, Arne Johannessen, Gerhard Hindricks, Håkan Walfridsson, Steen Pehrson, Anders Englund, Juha Hartikainen, Ole Kongstad, Leif Spange Mortensen, Peter Steen Hansen, MANTRA-PAF investigators

23 Citationer (Scopus)

Abstract

BACKGROUND: The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) is a randomized trial comparing radiofrequency catheter ablation (RFA) to antiarrhythmic drugs (AADs) as first-line treatment of paroxysmal atrial fibrillation (PAF). In order to eliminate the clouding effect of crossover we performed an on-treatment analysis of the data.

METHODS AND RESULTS: Patients (n=294) were divided into three groups: those receiving only the assigned therapy (RFA and AAD groups) and those receiving both therapies (crossover group). The primary end points were AF burden in 7-day Holter recordings at 3, 6, 12, 18, and 24months and cumulative AF burden in all recordings. At 24months, AF burden was significantly lower in the RFA (n=110) than in the AAD (n=92) and the crossover (n=84) groups (90th percentile 1% vs. 10% vs. 16%, P=0.007), and more patients were free from any AF (89% vs. 73% vs. 74%, P=0.006). In the RFA, AAD and the crossover groups 63%, 59% and 21% (P<0.001) of the patients had no AF episodes in any Holter recording, respectively. Quality of life improved significantly in all groups. There were no differences in serious adverse events between the RFA, AAD and crossover groups (19% vs. 8% vs. 23%) (P=0.10).

CONCLUSIONS: In the treatment of antiarrhythmic therapy naïve patients with PAF long-term efficacy of RFA was superior to AAD therapy. Thus, it is reasonable to offer RFA as first-line treatment for highly symptomatic patients who accept the risks of the procedure and are aware of frequent need for reablation(s).

OriginalsprogEngelsk
TidsskriftInternational Journal of Cardiology
Vol/bind198
Sider (fra-til)108-14
Antal sider7
ISSN0167-5273
DOI
StatusUdgivet - 1 nov. 2015

Fingeraftryk

Dyk ned i forskningsemnerne om 'Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater